The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Open accessAbstract
BACKGROUND: l-Carnitine, an abundant nutrient in red meat, accelerates atherosclerosis in mice via gut microbiota-dependent formation of trimethylamine (TMA) and trimethylamine N-oxide (TMAO) via a multistep pathway involving an atherogenic intermediate, γ-butyrobetaine (γBB). The contribution of γBB in gut microbiota-dependent l-carnitine metabolism in humans is unknown. METHODS: Omnivores and vegans/vegetarians ingested deuterium-labeled l-carnitine (d3-l-carnitine) or γBB (d9-γBB), and both plasma metabolites and fecal polymicrobial transformations were examined at baseline, following oral antibiotics, or following chronic (≥2 months) l-carnitine supplementation. Human fecal commensals capable of performing each step of the l-carnitine→γBB→TMA transformation were identified. RESULTS: Studies with oral d3-l-carnitine or d9-γBB before versus after antibiotic exposure revealed gut microbiota contribution to the initial 2 steps in a metaorganismal l-carnitine→γBB→TMA→TMAO pathway in subjects. Moreover, a striking increase in d3-TMAO generation was observed in omnivores over vegans/vegetarians (>20-fold; P = 0.001) following oral d3-l-carnitine ingestion, whereas fasting endogenous plasma l-carnitine and γBB levels were similar in vegans/vegetarians (n = 32) versus omnivores (n = 40). Fecal metabolic transformation studies, and oral isotope tracer studies before versus after chronic l-carnitine supplementation, revealed that omnivores and vegans/vegetarians alike rapidly converted carnitine to γBB, whereas the second gut microbial transformation, γBB→TMA, was diet inducible (l-carnitine, omnivorous). Extensive anaerobic subculturing of human feces identified no single commensal capable of l-carnitine→TMA transformation, multiple community members that converted l-carnitine to γBB, and only 1 Clostridiales bacterium, Emergencia timonensis, that converted γBB to TMA. In coculture, E. timonensis promoted the complete l-carnitine→TMA transformation. CONCLUSION: In humans, dietary l-carnitine is converted into the atherosclerosis- and thrombosis-promoting metabolite TMAO via 2 sequential gut microbiota-dependent transformations: (a) initial rapid generation of the atherogenic intermediate γBB, followed by (b) transformation into TMA via low-abundance microbiota in omnivores, and to a markedly lower extent, in vegans/vegetarians. Gut microbiota γBB→TMA/TMAO transformation is induced by omnivorous dietary patterns and chronic l-carnitine exposure. TRIAL REGISTRATION: ClinicalTrials.gov NCT01731236. FUNDING: NIH and Office of Dietary Supplements grants HL103866, HL126827, and DK106000, and the Leducq Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior research42,43 has suggested that vegans have lower TMAO levels than meat or fish eaters because of the TMAO precursors choline and carnitine in animal products.”
From Cardiometabolic Effects of Omnivorous vs Vegan Diets in Identical Twins: A Randomized Clinical Trial (2023) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Interestingly, in small cross-sectional observational studies, plasma levels of TMAO were modestly increased in omnivores relative to vegans/vegetarians, and in recent clinical challenge studies, TMA and TMAO generation from oral carnitine was observed to be substantially reduced in vegans/vegetarians.3,19”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [19]
In the citing paper
“Some of these TMA containing compounds can participate in TMA/TMAO formation in a gut microbiota-dependent manner, and also be generated by gut microbiota metabolism of L-carnitine.1,3,16,19”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [19]
In the citing paper
“Beyond choline and carnitine, potential nutrient precursors for TMA production have been reported, including the carnitine related metabolites c-butyrobetaine and crotonobetaine, and the choline oxidation product betaine.1,16,19”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [19]
In the citing paper
“Interestingly, in small cross-sectional observational studies, plasma levels of TMAO were modestly increased in omnivores relative to vegans/vegetarians, and in recent clinical challenge studies, TMA and TMAO generation from oral carnitine was observed to be substantially reduced in vegans/vegetarians.3,19”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [19]
In the citing paper
“The gut microbiota-derived metabolite TMAO has been linked to atherosclerotic heart disease in both mice and humans.185”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [185]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Self-citationIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Self-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Self-citationDiet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans
Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., González, A., Fontana, L., Henrissat, B., Knight, R., & Gordon, J. I. (2011) · Science · doi:10.1126/science.1198719 · Cited by 1,988
Seng, P., Drancourt, M., Gouriet, F., La Scola, B., Fournier, P., Rolain, J. M., & Raoult, D. (2009) · Clinical Infectious Diseases · doi:10.1086/600885 · Cited by 1,983
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Self-citationCarnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
Self-citationTang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Self-citationBennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Self-citationRomano, K. A., Vivas, E. I., Amador-Noguez, D., & Rey, F. E. (2015) · mBio · doi:10.1128/mbio.02481-14 · Cited by 777
Red Meat Consumption and Mortality: Results From 2 Prospective Cohort Studies
Sun, Q. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2287 · Cited by 763
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Wang, Z., Nicholls, S. J., Rodríguez, E. R., Kummu, O., Hörkkö, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A., & Hazen, S. L. (2007) · Nature Medicine · doi:10.1038/nm1637 · Cited by 722
Self-citationRole of gut microbiota in atherosclerosis
Jonsson, A. L., & Bäckhed, F. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 662
Schiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563 · cited 1×
“6% increased risk of all-cause mortality (45).”
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552
Self-citationγ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., Org, E., Wu, Y., Li, L., Smith, J. D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.006 · Cited by 546
Self-citationHeianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544 · cited 1×
“…unable to produce TMAO from l-carnitine had no antibiotic or probiotic exposure (like all subjects enrolled), were recruited from the same geographic region as the other subjects, and were appar-Figure and mortality risks across multiple patient populations and geographic areas (45–47).”
Uncovering the trimethylamine-producing bacteria of the human gut microbiota
Rath, S., Heidrich, B., Pieper, D. H., & Vital, M. (2017) · Microbiome · doi:10.1186/s40168-017-0271-9 · Cited by 515
Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation
Gregory, J. C., Buffa, J. A., Org, E., Wang, Z., Levison, B. S., Zhu, W., Wagner, M. A., Bennett, B. J., Li, L., DiDonato, J. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618249 · Cited by 486
Self-citationLi, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
Self-citationTrøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
Abete, I., Romaguera, D., Vieira, A. R., Lopez de Munain, A., & Norat, T. (2014) · British Journal of Nutrition · doi:10.1017/s000711451400124x · Cited by 448
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Self-citationKinetics, Pharmacokinetics, and Regulation of l‐Carnitine and Acetyl‐l‐carnitine Metabolism
Rebouche, C. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.003 · Cited by 426
Wang, X., Lin, X., Ouyang, Y. Y., Liu, J., Zhao, G., Pan, A., & Hu, F. B. (2016) · Public Health Nutrition · doi:10.1017/s1368980015002062 · Cited by 412
Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., Polhemus, D. J., Tang, W. H. W., Wu, Y., Hazen, S. L., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002314 · Cited by 382
Self-citationCarnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
Zhu, Y., Jameson, E., Crosatti, M., Schäfer, H., Rajakumar, K., Bugg, T. D. H., & Chen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316569111 · Cited by 372
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Miao, J., Ling, A. V., Manthena, P. V., Gearing, M. E., Graham, M. J., Crooke, R. M., Croce, K. J., Esquejo, R. M., Clish, C. B., Morbid Obesity Study Group, et al. (2015) · Nature Communications · doi:10.1038/ncomms7498 · Cited by 368
CARNITINE METABOLISM AND ITS REGULATION IN MICROORGANISMS AND MAMMALS
Rebouche, C. J., & Seim, H. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.39 · Cited by 362
L-Carnitine - Metabolic Functions and Meaning in Humans Life
Pękala, J., Patkowska-Sokoła, B., Bodkowski, R., Jamroz, D., Nowakowski, P., Lochyński, S., & Librowski, T. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504536 · Cited by 340
Shih, D. M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J. M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m051680 · Cited by 335
Self-citationUncovering effects of antibiotics on the host and microbiota using transkingdom gene networks
Morgun, A., Dzutsev, A., Dong, X., Greer, R. L., Sexton, D. J., Ravel, J., Schuster, M., Hsiao, W., Matzinger, P., & Shulzhenko, N. (2015) · Gut · doi:10.1136/gutjnl-2014-308820 · Cited by 315
Blaser, M. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci78366 · Cited by 303
Gut Microbe-Generated Trimethylamine N -Oxide From Dietary Choline Is Prothrombotic in Subjects
Zhu, W., Wang, Z., Tang, W. H. W., & Hazen, S. L. (2017) · Circulation · doi:10.1161/circulationaha.116.025338 · Cited by 274
Self-citationSenthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
Self-citationQi, J., You, T., Li, J., Pan, T., Xiang, L., Han, Y., & Zhu, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13307 · Cited by 268
Self-citationTrimethylamine N-oxide and prognosis in acute heart failure
Suzuki, T., Heaney, L. M., Bhandari, S. S., Jones, D. J. L., & Ng, L. L. (2016) · Heart · doi:10.1136/heartjnl-2015-308826 · Cited by 253
Sogawa, K., Watanabe, M., Sato, K., Segawa, S., Ishii, C., Miyabe, A., Murata, S., Saito, T., & Nomura, F. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4877-7 · Cited by 211
Skye, S. M., Zhu, W., Romano, K. A., Guo, C.-J., Wang, Z., Jia, X., Kirsop, J., Haag, B., Lang, J. M., DiDonato, J. A., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313142 · Cited by 189
Self-citationWall, B. T., Stephens, F. B., Constantin‐Teodosiu, D., Marimuthu, K., Macdonald, I. A., & Greenhaff, P. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201343 · Cited by 175
Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients
Shafi, T., Powe, N. R., Meyer, T. W., Hwang, S., Hai, X., Melamed, M. L., Banerjee, T., Coresh, J., & Hostetter, T. H. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030374 · Cited by 164
Zhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Self-citationAlisson-Silva, F., Kawanishi, K., & Varki, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.002 · Cited by 156
Radioisotopic determination of l-carnitine content in foods commonly eaten in Western countries
Demarquoy, J., Georges, B., Rigault, C., Royer, M.-C., Clairet, A., Soty, M., Lekounoungou, S., & Borgne, F. L. (2003) · Food Chemistry · doi:10.1016/j.foodchem.2003.09.023 · Cited by 148
Rebouche, C. J., & Chenard, C. A. (1991) · Journal of Nutrition · doi:10.1093/jn/121.4.539 · Cited by 147
Lo, W. K. C., Huff, G. S., Cubanski, J. R., Kennedy, A. D. W., McAdam, C. J., McMorran, D. A., Gordon, K. C., & Crowley, J. D. (2015) · Inorganic Chemistry · doi:10.1021/ic502557w · Cited by 124
Bacterial carnitine metabolism
Kleber, H.-P. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb10212.x · Cited by 118
Hydroxylation of γ-Butyrobetaine to Carnitine in Rat Liver*
Lindstedt, G. (1967) · Biochemistry · doi:10.1021/bi00857a007 · Cited by 115
Barnett, C., Costill, D. L., Vukovich, M. D., Cole, K. J., Goodpaster, B. H., Trappe, S. W., & Fink, W. J. (1994) · International Journal of Sport Nutrition · doi:10.1123/ijsn.4.3.280 · Cited by 107
Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise
VUKOVICH, M. D., COSTILL, D. L., & FINK, W. J. (1994) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199409000-00009 · Cited by 104
Mafune, A., Iwamoto, T., Tsutsumi, Y., Nakashima, A., Yamamoto, I., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1207-y · Cited by 103
A new method of quaternizing amines and its use in amino acid and peptide chemistry
Chen, F. C. M., & Benoiton, N. L. (1976) · Canadian Journal of Chemistry · doi:10.1139/v76-475 · Cited by 93
Multiple Isotopic Labels for Quantitative Mass Spectrometry
Morano, C., Zhang, X., & Fricker, L. D. (2008) · Analytical Chemistry · doi:10.1021/ac801654h · Cited by 88
The Effects of L-Carnitine Supplementation on Performance During Interval Swimming
Trappe, S., Costill, D., Goodpaster, B., Vukovich, M., & Fink, W. (1994) · International Journal of Sports Medicine · doi:10.1055/s-2007-1021044 · Cited by 66
Quantitative estimation of absorption and degradation of a carnitine supplement by human adults
Rebouche, C. J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90033-s · Cited by 61
Significance of renal gamma-butyrobetaine hydroxylase for carnitine biosynthesis in man.
Rebouche, C. J., & Engel, A. G. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43556-9 · Cited by 53
Verwertung von Trimethylammoniumverbindungen durch Acinetobacter calcoaceticus
Kleber, H. ‐., Seim, H., Aurich, H., & Strack, E. (1977) · Archives of Microbiology · doi:10.1007/bf00429336 · Cited by 53
The Effects of Acute L-carnitine Supplementation on Endurance Performance of Athletes
Örer, G. E., & Güzel, N. A. (2013) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3182a76790 · Cited by 46
Changes in l-carnitine content of fish and meat during domestic cooking
Rigault, C., Mazué, F., Bernard, A., Demarquoy, J., & Borgne, F. L. (2007) · Meat Science · doi:10.1016/j.meatsci.2007.06.011 · Cited by 46
Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogen.
Décombaz, J., Dériaz, O., Acheson, K. J., Gmuender, B., & Jéquier, E. (1993) · PubMed · Cited by 45
Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogen
Décombaz, J., Dériaz, O., Acheson, K. J., Gmuender, B., & Jéquier, E. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199306000-00014 · Cited by 36
Gandour, R. D., Colucci, W. J., Stelly, T. C., Brady, P. S., & Brady, L. J. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80558-7 · Cited by 15
Colucci, W. J., Turnbull, S. P., & Gandour, R. D. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90420-9 · Cited by 10
“Emergencia timonensis,” a new bacterium isolated from the stool of a healthy patient
Bessis, S., Ndongo, S., Lagier, J., Fournier, P., & Raoult, D. (2016) · New Microbes and New Infections · doi:10.1016/j.nmni.2016.05.001 · Cited by 9
Cited by
Sorted by citations
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,143
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Self-citationAnti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.578386 · Cited by 991
Metadata
- Authors
- Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., Culley, M. K., Li, X. S., Fu, X., Wu, Y., Li, L., DiDonato, J. A., Tang, W. H. W., Garcia-Garcia, J. C., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Procter & Gamble (United States) (US)
- Cleveland State University (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-12-10
- Volume
- 129
- Issue
- 1
- Pages
- 373-387
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6307959
- OpenAlex
- W2903641122
- Cited by
- 327
- References
- 65
- Citations by year
- 2026: 25 · 2025: 44 · 2024: 37 · 2023: 48 · 2022: 47 · 2021: 51 · 2020: 51 · 2019: 23 · 2018: 1
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH and Office of Dietary Supplements (HL103866, HL126827, DK106000)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Keywords
- L-carnitine, trimethylamine N-oxide, trimethylamine, gamma-butyrobetaine, gut microbiota, atherosclerosis, omnivorous diet, vegan diet, Clostridiales, antibiotic exposure, plasma carnitine
- MeSH terms
- Vegans, Eubacteriales, Clostridiales, Gastrointestinal Microbiome, Animals, Betaine, Carnitine, Female, Humans, Male, Methylamines, Pilot Projects, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
